Oral aspirin does not up FIT test sensitivity for ID’ing CRC

(HealthDay)—Administration of a single dose of oral aspirin prior to fecal immunochemical testing does not increase test sensitivity for detecting advanced colorectal neoplasms, according to a study published in the May 7 issue of the Journal of the American Medical Association. Hermann Brenner, M.D., M.P.H., from the German Cancer Research Center in Heidelberg, and colleagues conducted a randomized trial in […]

Continue reading »

PPIs combined with oral anticoagulants reduce risk of gastrointestinal bleeding

A Vanderbilt University Medical Center (VUMC) study published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant. Oral anticoagulants, which prevent blood clot formation, are among the most widely prescribed medications in the United States. […]

Continue reading »

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

Combinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial has now determined that cisplatin chemotherapy, combined with radiation therapy, produces the best results and should be considered the standard of care. Findings will be presented today at the 60th Annual Meeting of the […]

Continue reading »

Dwayne Johnson Claps Back at DJ Khaled's Oral Sex Comment: I Master 'ALL Performances'

Dwayne Johnson has a different opinion than DJ Khaled when it comes to the bedroom. In a recently resurfaced interview he gave in 2015 while appearing on The Breakfast Club, Khaled revealed that he thought it was a woman’s job to “praise the man — the king.” When asked, the DJ said that he would “never” perform oral sex on his wife — likely […]

Continue reading »

Sustained virological response to oral hepatitis C virus treatment associated with reduced mortality in Italian cohort

Patients with chronic hepatitis C virus (HCV) infection who achieve a sustained virological response (SVR) after direct-acting antiviral agent (DAA) treatment have lower all-cause mortality, according to a real-world study presented today at The International Liver Congress 2018 in Paris, France. The study, conducted in Italy, found that patients who achieved SVR were at reduced risk of death from both […]

Continue reading »

Oral sirolimus alters the course of DIPNECH syndrome in three patients

Sirolimus, which is used to prevent rejection after kidney transplants, has been used to successfully treat three cases of a rare disorder called diffuse idiopathic pulmonary neuroendocrine cell hyperplasia, or DIPNECH syndrome. The syndrome is so rare that there are no clinical recommendations to guide care and, therefore, no proven therapies. The brief case report is published in Annals of […]

Continue reading »